Does VINORELBINE Cause Diffuse large b-cell lymphoma refractory? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Diffuse large b-cell lymphoma refractory have been filed in association with VINORELBINE (Vinorelbine). This represents 0.2% of all adverse event reports for VINORELBINE.
11
Reports of Diffuse large b-cell lymphoma refractory with VINORELBINE
0.2%
of all VINORELBINE reports
1
Deaths
0
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From VINORELBINE?
Of the 11 reports, 1 (9.1%) resulted in death.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VINORELBINE. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does VINORELBINE Cause?
Off label use (644)
Malignant neoplasm progression (624)
Disease progression (526)
Neutropenia (517)
Nausea (504)
Drug ineffective (391)
Fatigue (373)
Diarrhoea (371)
Vomiting (342)
Anaemia (335)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which VINORELBINE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
VINORELBINE vs VINORELBINE\VINORELBINE
VINORELBINE vs VIREAD
VINORELBINE vs VISIPAQUE
VINORELBINE vs VISMODEGIB
VINORELBINE vs VITAMIN A